The Global Cell Culture Market is expected to grow from USD 16,371.34 Million in 2019 to USD 33,826.78 Million by the end of 2025 at a Compound Annual…

June 19, 2020 02:12 ET | Source: ReportLinker

New York, June 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Culture Market Research Report by Product, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913773/?utm_source=GNW The Consumables further studied across Bioreactor Accessories, Sera, Media, and Reagents, and Vessels. The Equipment further studied across Bioreactors, Storage Equipment, and Supporting Equipment.

On the basis of Application , the Cell Culture Market is studied across Biopharmaceutical Production, Diagnostics, Drug Screening and Development, Stem Cell Research, and Tissue Engineering & Regenerative Medicine.

On the basis of End User , the Cell Culture Market is studied across Cell Banks, Hospitals and Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.

On the basis of Geography, the Cell Culture Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Culture Market including Becton, Dickinson and Company, Cellgenix, Corning, Danaher, Eppendorf, Fujifilm Irvine Scientific, GE Healthcare, Hi-Media Laboratories, Invivogen, Lonza Group AG, Merck KGaA, Miltenyi Biotec, Promocell, and Sartorius AG.

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Culture Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Culture Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Culture Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Culture Market? 4. What is the competitive strategic window for opportunities in the Global Cell Culture Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Culture Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Culture Market? Read the full report: https://www.reportlinker.com/p05913773/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

More here:
The Global Cell Culture Market is expected to grow from USD 16,371.34 Million in 2019 to USD 33,826.78 Million by the end of 2025 at a Compound Annual...

Recombinant Cell Culture Supplements Market Industry Analysis, Size, Share, Upcoming Trends, Segmentation and Forecast to 2020 2024 – 3rd Watch News

The Global Recombinant Cell Culture Supplements Market Research Report Forecast 2020 2024 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Recombinant Cell Culture Supplements market and offers a clear assessment of the projected market fluctuations during the forecast period. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

(Exclusive Offer: Up to 20% discount on this report)

Get a Free Sample Copy of the Report before Purchase (including COVID19 Impact Analysis):

https://www.marketinsightsreports.com/reports/03061135921/global-recombinant-cell-culture-supplements-market-2019-by-manufacturers-countries-type-and-application-forecast-to-2024/inquiry?mode=69

Top Key Players in the Global Recombinant Cell Culture Supplements Market: BBI Solutions, Corning, Evercyte, Gemini Bio-Products, Lonza Group, Merck, Novozymes, Repligen, Thermo Fisher Scientific.

The increase in demand in cell culture project to gain increased productivity drive recombinant cell culture supplements markets globally. In addition, the increased use of animal supplement in the manufacture of vaccines, biopharmaceuticals and stem cells contribute to the growth of the market. Additional advantages of this supplement compared with conventional counterparts, animal-derived supplements, projected to encourage adoption recombinant cell culture media. Other factors that trigger the growth of recombinant cell culture supplement global markets increased investment in life science R & D and increased demand in the biotherapeutics industry. However, the high costs associated with research in cell biology and the consideration of some technical things necessary for cell culture are expected to inhibit the growth of the global market.

Market By Types:Recombinant Albumin Recombinant Insulin Recombinant Epidermal Growth Factor Recombinant Transferrin Others

Market By Applications:Stem Cell and Regenerative Medicine BioProduction Academic and Research Application

North America and Europe to Lead Recombinant Cell Culture Supplements Market

North America and Europe, together, hold approximately 65% market share globally recombinant cell culture supplement. Increasing the demand for cell culture products from biopharmaceutical companies, research institutes cancer, and others will encourage recombinant cell culture supplement market in this region. Increase funding for research of cell culture and biological pipeline networks by the major players in the region will further encourage recombinant cell culture supplement market.

Regional Analysis for Market:

For a comprehensive understanding of market dynamics, the global Recombinant Cell Culture Supplements market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India, and others. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

This Recombinant Cell Culture Supplements Market statistical surveying report underlines the leading merchants in this market everywhere throughout the world. This sector of the report includes market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. In a comparable way, automated gathering, upstream raw materials, and downstream demand studies are administered.

Browse in-depth and report summary TOC:

https://www.marketinsightsreports.com/reports/03061135921/global-recombinant-cell-culture-supplements-market-2019-by-manufacturers-countries-type-and-application-forecast-to-2024?mode=69

Influence of the Recombinant Cell Culture Supplements Market report:

-Comprehensive assessment of all opportunities and risks in the Recombinant Cell Culture Supplements Market.

-Recombinant Cell Culture Supplements Market recent innovations and major events.

-A Detailed study of business strategies for the growth of the Recombinant Cell Culture Supplements Market-leading players.

-Conclusive study about the growth plot of Recombinant Cell Culture Supplements Market for forthcoming years.

-In-depth understanding of Recombinant Cell Culture Supplements Market -particular drivers, constraints and major micro markets.

-Favorable impression inside vital technological and market latest trends striking the Recombinant Cell Culture Supplements Market.

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

-Analytical Tools: The Global Recombinant Cell Culture Supplements Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

The research includes historic data from 2015 to 2020 and forecasts until 2024 which makes the reports an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the Recombinant Cell Culture Supplements Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and Market development rate, and figure and so on. This report additionally Present a new task SWOT examination, speculation attainability investigation, and venture return investigation

Buy Full Reports:

https://www.marketinsightsreports.com/report/purchase/03061135921?mode=su?mode=69

Customization of this Report:This Recombinant Cell Culture Supplements market report could be customized to the customers requirements. Please contact our sales professional ([emailprotected]), we will ensure you obtain the report which works for your needs.

ABOUT US:

Market Insights Reports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Market Insights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected] | [emailprotected]

All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

See the rest here:
Recombinant Cell Culture Supplements Market Industry Analysis, Size, Share, Upcoming Trends, Segmentation and Forecast to 2020 2024 - 3rd Watch News

Impact of COVID-19 Outbreak on Cell Proliferation Kit, Global and Japan Market Insights, Forecast to 2026 – 3rd Watch News

In this report, the Impact of COVID-19 Outbreak on Cell Proliferation Kit, Global and Japan market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. Impact of COVID-19 Outbreak on Cell Proliferation Kit, Global and Japan market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/impact-of-covid-19-outbreak-on-cell-proliferation-kit-global-and-japan-market-insights-forecast-to-2026

Cell proliferation kit is an assay that delivers quick and profound quantification of cell proliferation and viability.

The test is based on division of tetrazolium salt WST-1 to formazan by cellular mitochondrial dehydrogenases. The increase in number of viable cells can be determined by amount of formazan dye produced by the reaction.

Market Analysis and Insights: Global and China Cell Proliferation Kit Market

This report focuses on global and China Cell Proliferation Kit market.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cell Proliferation Kit QYR Global and China market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Cell Proliferation Kit QYR Global and China industry.

Based on our recent survey, we have several different scenarios about the Cell Proliferation Kit QYR Global and China YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cell Proliferation Kit QYR Global and China will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Cell Proliferation Kit Scope and Market Size

Cell Proliferation Kit market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cell Proliferation Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

For China market, this report focuses on the Cell Proliferation Kit market size by players, by Type, and by Application, for the period 2015-2026. The key players include the global and local players which play important roles in China.

Segment by Type, the Cell Proliferation Kit market is segmented into

Colorimetric Detection Method

Fluorescent Detection Method

Other

Segment by Application, the Cell Proliferation Kit market is segmented into

Clinical

Industrial & Applied Science

Stem Cell Research

Regional and Country-level Analysis

The Cell Proliferation Kit market is analysed and market size information is provided by regions (countries).

The key regions covered in the Cell Proliferation Kit market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cell Proliferation Kit Market Share Analysis

Cell Proliferation Kit market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cell Proliferation Kit business, the date to enter into the Cell Proliferation Kit market, Cell Proliferation Kit product introduction, recent developments, etc.

The major vendors covered:

Biological Industries

Thermo Fisher Scientific

Sigma-Aldrich (Merck)

BD Biosciences

GE Healthcare

PerkinElmer

Millipoore (Merck)

Bio-Rad

Biotium

Mindray Medical

Browse full research report at https://www.crystalmarketreport.com/impact-of-covid-19-outbreak-on-cell-proliferation-kit-global-and-japan-market-insights-forecast-to-2026

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 911 Central Avenue #268 Albany New York 12206 Email: [emailprotected] Phone: 1-518-730-1569 Web: https://www.crystalmarketreport.com

Here is the original post:
Impact of COVID-19 Outbreak on Cell Proliferation Kit, Global and Japan Market Insights, Forecast to 2026 - 3rd Watch News

Stem Cell Therapy Shows Potential In Treating COVID-19 – Legal Examiner

As the coronavirus pandemic continues to affect millions of Americans in the U.S. alone, more than two million people have been infected and over 100,000 have died researchers are urgently seeking treatment options for COVID-19, the illness caused by the novel coronavirus. Because viruses arent treatable with antibiotics and can mutate quickly, it can be difficult for medical professionals to know the most effective course of treatment.

SARS-CoV-2, the strain of coronavirus responsible for COVID-19, has proven especially dangerous for elderly people and those with preexisting complications. About 14 percent of people over 80 who contract COVID-19 will die, and the virus hasnt shown any signs of slowing down.

While we await an effective vaccine to protect against the virus, there is a potentially promising solution: stem cell research. In May, the U.S. Food and Drug Administration approved a stem cell research trial for patients with severe cases of COVID-19. The trial includes 60 patients and uses stem cells from umbilical cord tissue.

Stem cells are a unique type of human cell that can generate new types of cells. Researchers are still discovering all of the potential benefits of stem cells, and they are sometimes used in cancer treatments like chemotherapy. Because COVID-19 currently has no definitive cure and medical professionals are still determining the best medications to treat severe cases, researchers are hopeful about the potential benefits of stem cells.

There are three main types of stem cells: embryonic, adult and pluripotent. Embryonic stem cells come from unused embryos donated after in-vitro fertilization, and they can evolve into more than one type of cell. Adult stem cells come from fully developed tissue and are typically more limited in the types of cells they can make. Pluripotent stem cells are adult stem cells that have been manipulated to be more similar to embryonic cells.

Were in the early stages of stem cell treatment for COVID-19, but there is reason to be hopeful about the promise they show. Stem cells can help control the bodys inflammatory response to a disease, and COVID-19 can cause both acute respiratory distress syndrome and pulmonary inflammation.

Right now, researchers are testing stem cell therapy with 300 patients around the U.S. All of the participants have severe cases of COVID-19 and are intubated, and about 1 in 4 coronavirus patients who are intubated will not survive. If all goes well with the clinical trial, which expects to have its results sometime in early 2021, stem cell treatment will be able to be used for even more patients and hopefully provide a way to improve the mortality rate and chances of recovery for coronavirus sufferers.

Read the original post:
Stem Cell Therapy Shows Potential In Treating COVID-19 - Legal Examiner

Worldwide Stem Cell Therapy Industry to 2027 – Growth in the Global Healthcare Market Presents Opportunities – PRNewswire

DUBLIN, June 18, 2020 /PRNewswire/ -- The "Stem Cell Therapy Market to 2027 - Global Analysis and Forecasts by Type; Treatment; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The stem cell therapy market was valued at US$ 1,534.55 million in 2019 and is estimated to reach US$ 5,129.66 million by 2027; it is expected to grow at a CAGR of 16.7% from 2020 to 2027.

The increasing awareness related to the stem cells therapy in effective disease management and growing demand for regenerative medicines are the key factor driving the stem cell therapy market. However, high cost related of the stem cell therapy limits the growth of the market.

Stem cell research has been widely investigated globally for various medical applications, especially for the treatment of humans. This raises the importance of creating public awareness about stem cell research and its clinical potential. The main role of stem cells is in the replacement of dying cells and reconstruction of damaged tissues. Based on the extensive stem cell research, many scientists have claimed that these cells could probably be used in the treatment of various diseases, including cancer and cardiovascular disease.

There is a large number of potential treatment procedures that are undergoing clinical trials, and a notably few stem cell therapies have won FDA (i.e., US -Food and Drug Administration) approval for clinical usage. For instance, in 2019, the FDA approved Fedratinib for the first-line treatment for myelofibrosis. Moreover, stem cell therapies are widely used in bone marrow transplantation, and these therapies have benefited thousands of people suffering from leukemia. Hematopoietic stem cells are used for treating more than 80 medical diseases, including immune system disorders, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and several types of cancers, such as leukemia and lymphoma; this is also likely to boost the demand for this treatment procedure during the forecast period. Researchers are further investigating the use of stem cell therapies in the treatment of autoimmune disorders.

The global stem cell therapy market has been segmented on the basis of type, treatment, application type, and end user. Based on type, the market has been segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and others. The adult stem cell therapy held the largest share of the market in 2019; however, induced pluripotent stem cell therapy is estimated to register the highest CAGR in the market during the forecast period. Based on treatment, the stem cell therapy market has been segmented into allogeneic and autologous. The allogeneic segment held a larger share of the market in 2019; however, the market for the autologous segment is expected to grow at a higher CAGR during the forecast period.

Reasons to Buy:

Key Topics Covered:

1. Introduction 1.1 Scope of the Study 1.2 Report Guidance 1.3 Market Segmentation 1.3.1 Global Stem Cell Therapy Market - By Type 1.3.2 Global Stem Cell Therapy Market - By Treatment 1.3.3 Global Stem Cell Therapy Market - By Application 1.3.4 Global Stem Cell Therapy Market - By End User 1.3.5 Global Stem Cell Therapy Market - By Geography

2. Stem Cell Therapy Market - Key Takeaways

3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research

4. Stem Cell Therapy - Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America 4.2.2 Europe 4.2.3 Asia Pacific 4.2.4 Middle East & Africa 4.2.5 South and Central America 4.3 Expert Opinion

5. Stem Cell Therapy Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Increasing Awareness Related to the Stem Cells Therapy in Effective Disease Management 5.1.2 Growing Demand For Regenerative Medicines 5.1.3 Growing Cancer Prevalence Across The Globe 5.2 Market Restraints 5.2.1 High Cost Related with Stem Cell Therapy 5.3 Market Opportunities 5.3.1 Growth in the Global Healthcare Market 5.4 Future Trends 5.4.1 Research Activities and Product Innovations 5.5 Impact Analysis

6. Stem Cell Therapy Market - Global Analysis 6.1 Global Stem Cell Therapy Market Revenue Forecast And Analysis 6.2 Global Stem Cell Therapy Market, By Geography - Forecast And Analysis 6.3 Market Positioning of Key Players

7. Global Stem Cell Therapy Market Analysis- by Type 7.1 Overview 7.2 Stem Cell Therapy Market Revenue Share, by Type (2019 and 2027) 7.3 Adult Stem Cell Therapy 7.3.1 Overview 7.3.2 Adult Stem Cell Therapy : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.3 Hematopoietic Stem Cell Therapy 7.3.3.1 Overview 7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.4 Umbilical Cord Stem Cell Therapy 7.3.4.1 Overview 7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.5 Neuronal Stem Cell Therapy 7.3.5.1 Overview 7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.3.6 Mesenchymal Stem Cell 7.3.6.1 Overview 7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4 Induced Pluripotent Stem Cell Therapy 7.4.1 Overview 7.4.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4.3 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.5 Embryonic Stem Cell Therapy 7.5.1 Overview 7.5.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.6 Other Stem Cell Therapy 7.6.1 Overview 7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Stem Cell Therapy Market Analysis- by Treatment 8.1 Overview 8.2 Stem Cell Therapy Market, by Treatment 2019 and 2027 (%) 8.3 Allogeneic 8.3.1 Overview 8.3.2 Allogeneic: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 8.4 Autologous 8.4.1 Overview 8.4.2 Autologous: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Stem Cell Therapy Market Analysis - by Application 9.1 Overview 9.2 Stem Cell Therapy Market Revenue Share, by Application (2019 and 2027) 9.3 Musculoskeletal 9.3.1 Overview 9.3.2 Musculoskeletal: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.4 Dermatology 9.4.1 Overview 9.4.2 Dermatology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.5 Cardiology 9.5.1 Overview 9.5.2 Cardiology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.6 Drug Discovery and Development 9.6.1 Overview 9.6.2 Drug Discovery and Development: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.7 Other Applications 9.7.1 Overview 9.7.2 Other Applications: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Stem Cell Therapy Market Analysis- by End User 10.1 Overview 10.2 Stem Cell Therapy Market, by End User 2019 and 2027 (%) 10.3 Academic & Research Institutes 10.3.1 Overview 10.3.2 Academic & Research Institutes: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.4 Hospitals & Specialty Clinics 10.4.1 Overview 10.4.2 Hospitals & Specialty Clinics : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Stem Cell Therapy Market - Geographic Analysis 11.1 North America: Stem Cell Therapy Market 11.2 Europe: Stem Cell Therapy Market 11.3 Asia Pacific: Stem Cell Therapy Market 11.4 Middle East & Africa: Stem Cell Therapy Market 11.5 South and Central America: Stem Cell Therapy Market

12. Stem Cell Therapy Market -Industry Landscape 12.1 Overview 12.2 Growth Strategies In The Stem Cell Therapy Market, 2015-2019 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview

13. COMPANY PROFILES 13.1 MEDIPOST 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Pharmicell Co., Inc. 13.3 RichSource 13.4 BioTime Inc. (Lineage Cell Therapeutics, Inc.) 13.5 Mesoblast Limited 13.6 Holostem Terapie Avanzate Srl 13.7 U.S. Stem Cell, Inc. 13.8 Caladrius Biosciences, Inc. 13.9 TiGenix NV 13.10 AlloSource

For more information about this report visit https://www.researchandmarkets.com/r/m8jwr5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See the original post:
Worldwide Stem Cell Therapy Industry to 2027 - Growth in the Global Healthcare Market Presents Opportunities - PRNewswire

‘Heart-in-a-dish’ to study the effects of coronavirus – British Heart Foundation

18 June 2020 Lisa Jones

Category: Research

BHF-funded researchers are using stem cell heart-in-a-dish technology - originally created to explore potential treatments for heart failure - to help understand how and why coronavirus (Covid-19) impacts the heart.

Dr Sanjay Sinha and his team at University of Cambridge will use their expertise in growing 2D and 3D heart tissue in the laboratory from human stem cells, to study how the coronavirus attaches to heart muscle cells and how it affects their ability to contract and relax.

By understanding how Covid-19 may impair heart function, the team will then be able to investigate potential protective treatments.

Dr Sinha is also exploring whether the immune response from Covid-19 is responsible for damaging the heart. Molecules called cytokines are part of the immune system and when theyre in high amounts they can cause inflammation. Covid-19 has been associated with a cytokine storm which can damage cells in the body.

To investigate this immune response on the heart, the team are obtaining blood samples from people with Covid-19 at a hospital in Cambridge. The blood serum which contains the cytokines will be added onto their lab-grown 2D and 3D heart muscle cells to see if there is anything in the infected blood that has a toxic effect on the heart.

Dr Sanjay Sinha, BHF-funded researcher at the University of Cambridge, said:

Through harnessing our existing heart-in-a-dish techniques were in a prime position to investigate how and why Covid-19 can have such a devastating impact on the heart. This new understanding should provide us with a test bed for screening drugs to protect the hearts of people with Covid-19.

Professor Metin Avkiran, our Associate Medical Director, said:

Were committed to supporting the fight against Covid-19. Many of our researchers, like Dr Sinha at the BHF Centre of Research Excellence in Cambridge, are applying their expertise to understanding the harmful and potentially deadly relationship between Covid-19 and the cardiovascular system.

With increasing evidence that people with severe Covid-19 may suffer heart damage, it is vital to understand if, and how, the coronavirus attacks heart muscle as a first step to finding new treatments. Pioneering research such as this could inform how we care for people who develop Covid-19 when theyre unwell and in their long-term recovery.

Our researchers and coronavirus

Read more:
'Heart-in-a-dish' to study the effects of coronavirus - British Heart Foundation

NIH announces new Transformative Research Award program for ALS – National Institutes of Health

News Release

Wednesday, June 17, 2020

New initiative encourages innovative research on devastating neurological disease.

The National Institutes of Health plans to invest $25 million over five years in a new program to spur innovative research on amyotrophic lateral sclerosis (ALS), a progressive and fatal neurological disease that weakens and eventually paralyzes voluntary muscles. Accelerating Leading-edge Science in ALS (ALS2) aims to answer critical questions about this disease.

Over the past few decades, there has been significant progress in our understanding of ALS, but we still do not have any breakthrough treatments for this terrible disease, said NIH Director Francis S. Collins, M.D., Ph.D. We hope this program will inject new ideas to the field to push us rapidly toward effective therapies.

Sometimes known as Lou Gehrigs disease, ALS is a neurodegenerative disease that affects motor neurons in the spinal cord that control voluntary muscles. For reasons that are currently unknown, the motor neurons die off, resulting in progressive muscle weakness that usually leads to respiratory failure. ALS is virtually always fatal, and many people die within three to five years of developing symptoms.

There is no cure for ALS. The U.S. Food and Drug Administration-approved drugs riluzole and edaravone can prolong life by a few months but do not improve symptoms. Ongoing clinical trials are looking at a range of therapeutic strategies including new drug candidates, devices to improve quality of life, and stem cell therapies. Genetic research has recently provided clues to understanding the disease, but it will take a focused investment in research from a range of scientific disciplines in order to capitalize on these insights.

ALS2 will be part of the NIH Common Funds High-Risk, High-Reward (HRHR) research program. The four initiatives of the HRHR program are a time-tested, powerful approach to sparking innovation. They support exceptionally creative research, which is inherently riskier, but has the potential to transform biomedical science. NIH will apply this potential to ALS2 through the HRHR programs Transformative Research Award initiative. The Transformative Research Award is particularly well-suited to interdisciplinary teams of scientists looking to combine their expertise and pursue new ideas with the potential to transform ALS research.

ALS2 will take a three-pronged approach to improve understanding of ALS:

Information on a Notice of Special Interest to accompany the Transformative Research Award funding opportunity will be posted here: https://commonfund.nih.gov/tra/grants.

This initiative is managed collaboratively by the NIH Common Fund, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institute of Environmental Health Sciences, and the National Institute of General Medical Sciences.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Original post:
NIH announces new Transformative Research Award program for ALS - National Institutes of Health

Global Stem Cell Therapy for Osteoarthritis Market 2020: Expected Development, Share, Demand And Study Of Key Players- Research Predictions 2025 -…

Global Stem Cell Therapy for Osteoarthritis Market 2020 by Company, Regions, Type and Application, Forecast to 2025 aims to project the value and volume of the market and strategically profile the key players, analyze their growth strategies. The report delivers in-depth data and study of the industry dynamics of this market. The report offers an overview of global Stem Cell Therapy for Osteoarthritis market division like type, application, and region. The market report dynamics trends are made up of opportunities and challenges. The report provides a structure of the market and predicts industry share to rise within the forecast period 2025. The research thoroughly estimates the consumption volume industry by application, manufacturing technology and regions. Further, conclusion, discoveries, and future improvement openings are explored in the report.

The market report opens with an overview of the global Stem Cell Therapy for Osteoarthritis industry, which contains definitions and specifications about the industry. In the next chapter, the report explains the manufacturing cost structure, which includes a thorough analysis of the raw material suppliers and price analysis, equipment suppliers and price analysis, and analysis of labour costs and other costs. The manufacturers have been incorporated in terms of their manufacturing base, basic information, and competitors.

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Stem Cell Therapy for Osteoarthritis market.

DOWNLOAD FREE SAMPLE REPORT: https://www.researchstore.biz/sample-request/19520

Our best analysts have surveyed the market report with the reference of inventories and data given by the key players: Mesoblast, Anterogen, Regeneus, U.S. Stem Cell, Asterias Biotherapeutics

On the basis on the applications, this report focuses on the status and outlook for major applications/end users, sales volume, and growth rate for each application, including: Osteoarthritis (unspecified), Knee Osteoarthritis, Shoulder Osteoarthritis, Hip Osteoarthritis,

On the basis of types/products, this report displays the revenue (Million USD), product price, market share, and growth rate of each type, split into: Monotherapy, Combination Therapy,

Key Issues Addressed by Market:

It is very significant to have global Stem Cell Therapy for Osteoarthritis segmentation analysis to figure out the essential factors of growth and development of the market. The report provides well summarized and reliable information about every segment of growth, development, production, demand, types, application of the specific product which will assist players to focus and highlight on.

Moreover, each geographic segment of the global Stem Cell Therapy for Osteoarthritis market has been independently surveyed along with pricing, distribution and demand data for geographic market notably: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East& Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

ACCESS FULL REPORT: https://www.researchstore.biz/report/global-stem-cell-therapy-for-osteoarthritis-market-19520

The Key Benefit of This Report:

Customization of the Report: This report can be customized to meet the clients requirements. Please connect with our sales team (sales@researchstore.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Researchstore.biz is a fully dedicated global market research agency providing thorough quantitative and qualitative analysis of extensive market research.Our corporate is identified by recognition and enthusiasm for what it offers, which unites its staff across the world.We are desired market researchers proving a reliable source of extensive market analysis on which readers can rely on. Our research team consist of some of the best market researchers, sector and analysis executives in the nation, because of which Researchstore.biz is considered as one of the most vigorous market research enterprises. Researchstore.biz finds perfect solutions according to the requirements of research with considerations of content and methods. Unique and out of the box technologies, techniques and solutions are implemented all through the research reports.

Contact Us Mark Stone Head of Business Development Phone: +1-201-465-4211 Email: sales@researchstore.biz Web: http://www.researchstore.biz

Read the rest here:
Global Stem Cell Therapy for Osteoarthritis Market 2020: Expected Development, Share, Demand And Study Of Key Players- Research Predictions 2025 -...

Cambridge team probes COVID-19 impact on the heart – Business Weekly

University of Cambridge researchers are leveraging stem cell heart-in-a-dish technology to study the effects of coronavirus on the critical organ.

The technology was originally devised to explore potential treatments for heart failure. Now the British Heart Foundation is funding the team to help understand how and why COVID-19 impacts the heart.

Dr Sanjay Sinha and his team will exploit their expertise in growing 2D and 3D heart tissue in the laboratory from human stem cells to study how the coronavirus attaches to heart muscle cells and how it affects their ability to contract and relax.

By understanding how COVID-19 may impair heart function, the team will then be able to investigate potential protective treatments.

Dr Sinha is also exploring whether the immune response from COVID-19 is responsible for damaging the heart. Molecules called cytokines are part of the immune system and when theyre in high amounts they can cause inflammation. COVID-19 has been associated with a cytokine storm which can damage cells in the body.

To investigate this immune response on the heart, the team are obtaining blood samples from people with COVID-19 at a hospital in Cambridge.

The blood serum which contains the cytokines will be added onto their lab-grown 2D and 3D heart muscle cells to see if there is anything in the infected blood that has a toxic effect on the heart.

Dr Sinha said: Through harnessing our existing heart-in-a-dish techniques were in a prime position to investigate how and why COVID-19 can have such a devastating impact on the heart.

This new understanding should provide us with a test bed for screening drugs to protect the hearts of people with COVID-19.

Professor Metin Avkiran, BHFs Associate Medical Director, added: Were committed to supporting the fight against COVID-19. Many of our researchers, like Dr Sinha at the BHF Centre of Research Excellence in Cambridge, are applying their expertise to understanding the harmful and potentially deadly relationship between COVID-19 and the cardiovascular system.

With increasing evidence that people with severe COVID-19 may suffer heart damage it is vital to understand if, and how, the coronavirus attacks heart muscle as a first step to finding new treatments.

Pioneering research such as this could inform how we care for people who develop COVID-19 when theyre unwell and in their long-term recovery.

View original post here:
Cambridge team probes COVID-19 impact on the heart - Business Weekly

Impact of COVID-19 on Stem Cell Assay Market To Experience Significant Growth During The Forecast Period 2020-2027 | By Top Key Players Merck &…

Notice:This Content doesnt contains all the Information of the Report please fill the form (via link) and get all interesting information just one click in PDF with latest update with chart and Table of Content

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Stem Cell Assay market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

This Report Covers Leading Companies Associated in Worldwide Stem Cell Assay Market: Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/1632

The report begins with a brief introduction and market overview of the Stem Cell Assay industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed along with current trends and policies in the industry.

The key players profiled in this report include: Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Get a PDF Brochure of this Report: https://www.coherentmarketinsights.com/insight/request-pdf/1632

Key Benefits:

o This study gives a detailed analysis of drivers and factors limiting the market expansion of Stem Cell Assay

o The micro-level analysis is conducted based on its product types, end-user applications, and geographies

o Porters five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

o By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Stem Cell Assay market

The research study can answer the following Key questions:

Table of Contents

Report Overview: It includes the Stem Cell Assay market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Stem Cell Assay market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Stem Cell Assay market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Stem Cell Assay market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Get Offer on Report: https://www.coherentmarketinsights.com/insight/request-discount/1632

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: Coherent Market Insights, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com Phone: US +1-206-701-6702/UK +44-020 8133 4027

See the rest here:
Impact of COVID-19 on Stem Cell Assay Market To Experience Significant Growth During The Forecast Period 2020-2027 | By Top Key Players Merck &...